<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-4943785529918190981</id><updated>2011-04-21T20:55:16.077-07:00</updated><category term='Grounds'/><category term='Chapter 4'/><category term='introduction'/><category term='Opposition attraction'/><category term='Re-inventing inventions'/><category term='Controller&apos;s Decision'/><category term='Chapter 7'/><category term='Practice'/><category term='Chapter 9'/><category term='Chapter 8'/><category term='Touchstone effect'/><category term='Chapter 6'/><category term='Chapter 10'/><category term='black swan'/><category term='Strategy'/><category term='search blog'/><category term='book'/><category term='Chapter 3'/><category term='Beyond opposition'/><title type='text'>The Touchstone Effect</title><subtitle type='html'>An Online Companion to the Book "The Touchstone Effect:The Impact of Pre-grant Opposition on Patents"</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>57</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-89751393725850989</id><published>2008-11-22T08:34:00.000-08:00</published><updated>2008-11-22T08:55:14.974-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='search blog'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>How to look for things here</title><content type='html'>&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 10"&gt;&lt;meta name="Originator" content="Microsoft Word 10"&gt;&lt;link style="font-family: georgia;" rel="File-List" href="file:///C:%5CDOCUME%7E1%5Cuser%5CLOCALS%7E1%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;  &lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-parent:""; 	margin:0in; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman";} a:link, span.MsoHyperlink 	{color:blue; 	text-decoration:underline; 	text-underline:single;} a:visited, span.MsoHyperlinkFollowed 	{color:purple; 	text-decoration:underline; 	text-underline:single;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.25in 1.0in 1.25in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;}  /* List Definitions */  @list l0 	{mso-list-id:1621374260; 	mso-list-type:hybrid; 	mso-list-template-ids:476496044 -1811525668 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;} @list l0:level1 	{mso-level-tab-stop:.75in; 	mso-level-number-position:left; 	margin-left:.75in; 	text-indent:-.5in;} ol 	{margin-bottom:0in;} ul 	{margin-bottom:0in;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin:0in; 	mso-para-margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:10.0pt; 	font-family:"Times New Roman";} &lt;/style&gt; &lt;![endif]--&gt;  &lt;p  style="text-align: justify;font-family:georgia;" class="MsoNormal"&gt;&lt;span style=";font-family:georgia;font-size:100%;"  &gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:georgia;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;br /&gt;You can search for Controller’s decision on pre-grant opposition through different search terms. You can type the relevant search term on the ‘search box’ on top of the blog and press ‘search blog’ button. Here’s a brief illustration on the ways you can search for decisions using the search box:&lt;br /&gt;&lt;ol&gt;&lt;li&gt;Search by party’s name (the applicant or the opponent) you are looking for. For example, type ‘Novartis’ for the decisions concerning Novartis’s applications; type ‘Ranbaxy’ for the decisions where Ranbaxy opposed other’s patent applications.&lt;/li&gt;&lt;li&gt;Search by patent application number. For example, type ‘1602/MAS/1998’ to find the decision concerning the relevant application.&lt;/li&gt;&lt;li&gt;Search by patent office. For example, type ‘BOM’ or ‘MUM’ for the decisions of the Mumbai Patent Office, ‘CHE’ or ‘MAS’ for the Chennai office and so on.&lt;/li&gt;&lt;li&gt;Search by subject. As these decisions figure in the Book in various chapters, you can search by the key word of that chapter. Eg Chapter 10 is titled ‘Strategic Opposition of Patents’. You can get all the decisions in chapter 10 by typing ‘strategy’ in the search box.&lt;br /&gt;&lt;/li&gt;&lt;li&gt;To get all the decisions in one page, simply type ‘Controller’s decision’.                 &lt;/li&gt;&lt;/ol&gt;&lt;br /&gt;You can also click on the ‘&lt;a href="http://pharmapatent.googlegroups.com/web/table+of+cases+-+TTE.pdf?gda=KKCDzkoAAADfRe7hc4_l5Qxcp09gGRdPHDBehy5iPZRZ-w-Az5fBit4V1nCeThVzMY8kXHbBB43nRaXjTBBhd8cDn1qWuNMh_e3Wg0GnqfdKOwDqUih1tA&amp;amp;gsc=9jTEZRYAAABuGlJQ17g4M00fRjyuSi0O57an5Fe8QJeePd7zpGv9tg"&gt;Table of cases&lt;/a&gt;’ under links which you can find on the left hand side of the blog to get the broad view of the cases discussed in the Book. As most of the decisions were downloaded (in ‘as is where is’ condition) from the Patent Office &lt;a href="http://www.patentoffice.nic.in"&gt;website&lt;/a&gt;, the usual disclaimers apply.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-89751393725850989?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/89751393725850989/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=89751393725850989' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/89751393725850989'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/89751393725850989'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/how-to-look-for-things-here.html' title='How to look for things here'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-246084800564902833</id><published>2008-11-17T08:34:00.000-08:00</published><updated>2008-11-17T08:42:33.904-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Warner-Lambert Co’s Application/ Opposition by Torrent Pharmaceuticals Ltd (No 1577/DEL/1996)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1577-del-1996.pdf?gda=i0a6V0MAAADfRe7hc4_l5Qxcp09gGRdPdVvWZpz3_hZcCtbrso7D3QP3GbR7_YkyQwK_8zcrNoQytiJ-HdGYYcPi_09pl8N7FWLveOaWjzbYnpnkpmxcWg&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 83,85,156 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-246084800564902833?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/246084800564902833/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=246084800564902833' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/246084800564902833'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/246084800564902833'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/warner-lambert-cos-application.html' title='Warner-Lambert Co’s Application/ Opposition by Torrent Pharmaceuticals Ltd (No 1577/DEL/1996)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-511638375454289420</id><published>2008-11-17T08:32:00.000-08:00</published><updated>2008-11-17T08:47:39.339-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Thomson Licensing’s Application (No 1608/DELNP/2005)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1608-delnp-2005.pdf?gda=0FF-NUUAAADfRe7hc4_l5Qxcp09gGRdPO3B8PAQwqVYgdAGjOunbrk09zIb77x1eX19SanBqMRccn8WIbWh5zqeDKtDBmq67Gu1iLHeqhw4ZZRj3RjJ_-A&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 94 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-511638375454289420?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/511638375454289420/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=511638375454289420' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/511638375454289420'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/511638375454289420'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/thomson-licensings-application-no.html' title='Thomson Licensing’s Application (No 1608/DELNP/2005)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-8013195609781892274</id><published>2008-11-17T08:29:00.000-08:00</published><updated>2008-11-17T08:48:57.756-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Star Precision Electronics Ltd’s Application / Opposition by Premier Polytronics Ltd [No 180043(307/BOM/1994)]</title><content type='html'>Click&lt;a href="http://pharmapatent.googlegroups.com/web/307-bom-94+star+precision+premier.pdf?gda=k0JcSFcAAADfRe7hc4_l5Qxcp09gGRdPYpeQbW2AZ2jCgFhbGflTnIIXuEaTKkGbBKb3DBZIcUk4V4KWDOfEMzKPD_Uj4sjpYZqzEd7hr7z69NT6IftdMXleHbr-qQzBoYYWXY0JTQM&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt; here&lt;/a&gt; for the decision. For more details see page 154 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-8013195609781892274?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/8013195609781892274/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=8013195609781892274' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8013195609781892274'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8013195609781892274'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/star-precision-electronics-ltds.html' title='Star Precision Electronics Ltd’s Application / Opposition by Premier Polytronics Ltd [No 180043(307/BOM/1994)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-106148339714226487</id><published>2008-11-17T08:24:00.000-08:00</published><updated>2008-11-17T08:49:56.093-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Star Precision Electronics Ltd’s Application / Opposition by Premier Polytronics Ltd [No 176369 (278/BOM/1993)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/278-bom-93+star+precision+premeir.pdf?gda=S9VLhVcAAADfRe7hc4_l5Qxcp09gGRdPwp0R6696R2uRkSe13VCkbLyszxmrdRRaP85Yev_4LqbF6i24u8Xy3atjTGVtgQKWYZqzEd7hr7z69NT6IftdMXleHbr-qQzBoYYWXY0JTQM&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 96 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-106148339714226487?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/106148339714226487/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=106148339714226487' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/106148339714226487'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/106148339714226487'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/star-precision-electronics-ltds_17.html' title='Star Precision Electronics Ltd’s Application / Opposition by Premier Polytronics Ltd [No 176369 (278/BOM/1993)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1949578430458709665</id><published>2008-11-17T08:22:00.000-08:00</published><updated>2008-11-17T08:51:03.085-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>SPL’s Sidhartha Ltd’s Application/ Opposition by Newage Laminators Ltd [No 191793 (861 /DEL/2000)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/861-del-2000.pdf?gda=ln_YTkIAAADfRe7hc4_l5Qxcp09gGRdPNadYTC4NlLLo4lMFrQagzho2miK7F8CL97I6BPndlV9V4u3aa4iAIyYQIqbG9naPgh6o8ccLBvP6Chud5KMzIQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1949578430458709665?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1949578430458709665/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1949578430458709665' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1949578430458709665'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1949578430458709665'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/spls-sidhartha-ltds-application.html' title='SPL’s Sidhartha Ltd’s Application/ Opposition by Newage Laminators Ltd [No 191793 (861 /DEL/2000)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-8133210578825425283</id><published>2008-11-17T08:21:00.000-08:00</published><updated>2008-11-17T08:52:28.744-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Beyond opposition'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 9'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Schering Corporation’s Application/ Opposition by Cadila Healthcare Ltd (IN/PCT/2000/00434/CHE)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/in-pct-2000-00434-che+schering+cadila.pdf?gda=4VNXwlsAAADfRe7hc4_l5Qxcp09gGRdPuakrSuwRrWwx_QzKYB7DGJyvXdYNaKk2lKiZxpDtJICGipsUjZa81LdYTce21mABrKpA5YZPdoKGLHQ1o1L0nAZF2vdCvKU-TDZpFtcP-AU&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-8133210578825425283?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/8133210578825425283/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=8133210578825425283' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8133210578825425283'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8133210578825425283'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/schering-corporations-application.html' title='Schering Corporation’s Application/ Opposition by Cadila Healthcare Ltd (IN/PCT/2000/00434/CHE)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1318712263700264644</id><published>2008-11-17T08:19:00.000-08:00</published><updated>2008-11-17T08:54:09.720-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Rhone-Poulenc Chimie’s Patent/ Opposition by Indian Space Research Organisation [No 187575 (1065/MAS/1994)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1065mas94+Rhone+Poulenc+ISRO.pdf?gda=wIAYYFIAAADfRe7hc4_l5Qxcp09gGRdP-1lWm8MH8-l6gT7foGC6RzTd7TyHv-NKfe_ZCuE7z9yuq9u5zxRL9zvHOKjS__OmVeLt2muIgCMmECKmxvZ2j4IeqPHHCwbz-gobneSjMyE&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 111 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1318712263700264644?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1318712263700264644/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1318712263700264644' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1318712263700264644'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1318712263700264644'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/rhone-poulenc-chimies-patent-opposition.html' title='Rhone-Poulenc Chimie’s Patent/ Opposition by Indian Space Research Organisation [No 187575 (1065/MAS/1994)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-2260574438362950058</id><published>2008-11-17T08:18:00.000-08:00</published><updated>2008-11-17T08:56:57.724-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 6'/><category scheme='http://www.blogger.com/atom/ns#' term='Opposition attraction'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Real Value Appliances’ Application/ Opposition by Premsons Plastics [No 174043 (247/BOM/1991)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/247-bom-91+real+value+permsons+plastics.pdf?gda=TPXgRV0AAADfRe7hc4_l5Qxcp09gGRdPnJbkUgagPfFD01CxHLBOckzvd8xE9m2s9uiTOR0esqRfpdl2R-YJetrNBjui3DFqlwBIHokKlyEzhRTEJguv5uU2_747KStNgkfeVUa7Znk&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 64 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-2260574438362950058?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/2260574438362950058/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=2260574438362950058' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2260574438362950058'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2260574438362950058'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/real-value-appliances-application.html' title='Real Value Appliances’ Application/ Opposition by Premsons Plastics [No 174043 (247/BOM/1991)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1868757385548786175</id><published>2008-11-17T08:17:00.000-08:00</published><updated>2008-11-17T08:59:08.126-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Polytech Research’s Application/ Opposition by Cosmo Films Ltd [No 1824062 (941/DEL/1991)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/941-del-91+polytech+cosmo+films.pdf?gda=FB3PqlUAAADfRe7hc4_l5Qxcp09gGRdPYxUN-AhhCcjK-pb8FmSvS-xY92Fw5ffTf0CgZmH2MjwufHoKLosHjQrPlfrn9ViIHJ_FiG1oec6ngyrQwZquuxrtYix3qocOGWUY90Yyf_g&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 153,154 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1868757385548786175?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1868757385548786175/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1868757385548786175' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1868757385548786175'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1868757385548786175'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/polytech-researchs-application.html' title='Polytech Research’s Application/ Opposition by Cosmo Films Ltd [No 1824062 (941/DEL/1991)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-3574040381146094472</id><published>2008-11-17T08:16:00.000-08:00</published><updated>2008-11-17T09:01:03.948-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Beyond opposition'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 9'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Piaggio’s Application/ Opposition by Bajaj Auto Ltd [No 184001 (557/DEL/1991)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/557-del-91+Piaggio+Bajaj.pdf?gda=VpDSV04AAADfRe7hc4_l5Qxcp09gGRdPhE7BKToxP57pnE0iqBKIRDMeEJZuQgiEZt1YtjD7ggDSWKWb3xkylc51n_diM7eU47Cl1bPl-23V2XOW7kn5sQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 134,155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-3574040381146094472?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/3574040381146094472/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=3574040381146094472' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3574040381146094472'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3574040381146094472'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/piaggios-application-opposition-by.html' title='Piaggio’s Application/ Opposition by Bajaj Auto Ltd [No 184001 (557/DEL/1991)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-3949617731499595616</id><published>2008-11-17T08:14:00.000-08:00</published><updated>2008-11-17T09:02:50.116-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Pfizer Health AB’s Application/ Opposition by Ranbaxy Laboratories Ltd (IN/PCT/2001/00788/CHE)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/in-pct-2001-00788-che+pfizer+ranb.pdf?gda=pnxNdFcAAADfRe7hc4_l5Qxcp09gGRdPuakrSuwRrWwx_QzKYB7DGEE4AXU_Zb3T3SKlW5anZ9MXVWV7kZUIQfbB7gTj3SBxYZqzEd7hr7z69NT6IftdMXleHbr-qQzBoYYWXY0JTQM&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 116,136 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-3949617731499595616?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/3949617731499595616/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=3949617731499595616' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3949617731499595616'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3949617731499595616'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/pfizer-health-abs-application.html' title='Pfizer Health AB’s Application/ Opposition by Ranbaxy Laboratories Ltd (IN/PCT/2001/00788/CHE)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-7857515199426335981</id><published>2008-11-17T08:12:00.000-08:00</published><updated>2008-11-17T09:06:32.989-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Beyond opposition'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 9'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Pfizer Health AB’s Application/ Opposition by Ranbaxy Laboratories Ltd (IN/PCT/2000/00084/CHE)</title><content type='html'>Click&lt;a href="http://pharmapatent.googlegroups.com/web/inpct2000_00084_che+pfizer+ranb.pdf?gda=Za6MiFUAAADfRe7hc4_l5Qxcp09gGRdPuakrSuwRrWwx_QzKYB7DGGl8r60JQNtggi2_kImdGx0GNd3yrA7CJz7xrEtS22QmHJ_FiG1oec6ngyrQwZquuxrtYix3qocOGWUY90Yyf_g&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt; here&lt;/a&gt; for the decision. For more details see pages 85,94,103,136,155  of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-7857515199426335981?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/7857515199426335981/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=7857515199426335981' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7857515199426335981'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7857515199426335981'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/pfizer-health-abs-application_17.html' title='Pfizer Health AB’s Application/ Opposition by Ranbaxy Laboratories Ltd (IN/PCT/2000/00084/CHE)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-6223851033095747724</id><published>2008-11-17T08:10:00.000-08:00</published><updated>2008-11-17T09:10:28.170-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Pfizer Products Inc’s Application/ Opposition by Natco Pharma Ltd (No 537/DEL/1996)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/537del96+Pfizer+Natco.pdf?gda=QaO9lUsAAADfRe7hc4_l5Qxcp09gGRdPIvS2-FTHh8PMZZHkZ2c_5twl9O5CVddPs1BXUstmQloEzOSJiKi22_1YXxHpPPwOBkXa90K8pT5MNmkW1w_4BQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 84,87,108,112,115,118  of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-6223851033095747724?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/6223851033095747724/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=6223851033095747724' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6223851033095747724'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6223851033095747724'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/pfizer-products-incs-application.html' title='Pfizer Products Inc’s Application/ Opposition by Natco Pharma Ltd (No 537/DEL/1996)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-6060666860554530188</id><published>2008-11-17T08:09:00.000-08:00</published><updated>2008-11-17T09:11:48.864-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Patent Application No 195/MUM/NP/03</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/195-mumnp-2003.pdf?gda=_U0ypkQAAADfRe7hc4_l5Qxcp09gGRdP9dXwNjim9yKWXUESbjtXofj8ZuiF7CJXi6xt_1WIU59V6u9SiETdg0Q2ffAyHU-dzc4BZkLnSFWX59nr5BxGqA&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 154 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-6060666860554530188?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/6060666860554530188/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=6060666860554530188' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6060666860554530188'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6060666860554530188'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/patent-application-no-195mumnp03.html' title='Patent Application No 195/MUM/NP/03'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-6068053186530267571</id><published>2008-11-17T08:08:00.000-08:00</published><updated>2008-11-17T09:12:40.904-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Novartis AG’s Application/ Opposition by Torrent Pharmaceuticals Ltd (IN/PCT/2001/00864/CHE)</title><content type='html'>Click&lt;a href="http://pharmapatent.googlegroups.com/web/in+pct+2001+00864+che.pdf?gda=vK_eoksAAADfRe7hc4_l5Qxcp09gGRdPuakrSuwRrWwx_QzKYB7DGL4837rNjhbbl5czwJ_YcE6FiYJ-UBm6e7VKcxxEdu5ABkXa90K8pT5MNmkW1w_4BQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt; here&lt;/a&gt; for the decision. For more details see page 87 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-6068053186530267571?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/6068053186530267571/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=6068053186530267571' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6068053186530267571'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6068053186530267571'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/novartis-ags-application-opposition-by.html' title='Novartis AG’s Application/ Opposition by Torrent Pharmaceuticals Ltd (IN/PCT/2001/00864/CHE)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-3601834160407130056</id><published>2008-11-17T08:04:00.000-08:00</published><updated>2008-11-17T09:14:02.912-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Novartis AG’s Application/ Opposition by Ranbaxy Laboratories Ltd (No 1602/MAS/1998)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1602mas98+novartis+cipla.pdf?gda=viV1rk4AAADfRe7hc4_l5Qxcp09gGRdPO3B8PAQwqVYgdAGjOunbrjvu-B6FB8jnSp-xdnx6_2n0AfpmY7PnFH-2OqBb1pgz47Cl1bPl-23V2XOW7kn5sQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 136 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-3601834160407130056?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/3601834160407130056/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=3601834160407130056' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3601834160407130056'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3601834160407130056'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/novartis-ags-application-opposition-by_17.html' title='Novartis AG’s Application/ Opposition by Ranbaxy Laboratories Ltd (No 1602/MAS/1998)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-7901445203838489175</id><published>2008-11-17T08:03:00.000-08:00</published><updated>2008-11-17T09:16:35.723-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Novartis AG’s Application/ Opposition by Ranbaxy Laboratories Ltd (No 1440/MAS/1998)</title><content type='html'>Click&lt;a href="http://pharmapatent.googlegroups.com/web/1440mas98+Novartis+Ranbaxy.pdf?gda=f_Rzc1AAAADfRe7hc4_l5Qxcp09gGRdPqRVHMYUKgJ68ZnmyLD1pzLV21qfu1AMlBlkwBvcd0TvR2uKXGoHTs1-dzS1qSMX7bcVT3VtYGKLco-_l-8AzjQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt; here&lt;/a&gt; for the decision. For more details see pages 82,136,153 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-7901445203838489175?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/7901445203838489175/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=7901445203838489175' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7901445203838489175'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7901445203838489175'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/novartis-ags-application-opposition-by_4584.html' title='Novartis AG’s Application/ Opposition by Ranbaxy Laboratories Ltd (No 1440/MAS/1998)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-3035564541445205230</id><published>2008-11-17T08:02:00.000-08:00</published><updated>2008-11-17T09:18:38.221-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Novartis AG’s Application/ Opposition by Ranbaxy Laboratories Ltd (No 237/MAS/1998)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/237-mas-98+novartis.pdf?gda=KDKzMkkAAADfRe7hc4_l5Qxcp09gGRdPUr7jRzN4us8uJ3DwA8SZ1gL7avQ5Ar-odjuHf0BCXsCyReiVSH9JHBqhfXgoGtYIhAioEG5q2hncZWbpWmJ7IQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 91,118 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-3035564541445205230?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/3035564541445205230/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=3035564541445205230' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3035564541445205230'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3035564541445205230'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/novartis-ags-application-opposition-by_1637.html' title='Novartis AG’s Application/ Opposition by Ranbaxy Laboratories Ltd (No 237/MAS/1998)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-2653626484266847508</id><published>2008-11-17T08:00:00.000-08:00</published><updated>2008-11-17T09:22:26.315-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Novartis AG’s Application/ Opposition by Cipla Ltd (No 1602/MAS/1998)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1602mas98+novartis+cipla.pdf?gda=viV1rk4AAADfRe7hc4_l5Qxcp09gGRdPO3B8PAQwqVYgdAGjOunbrjvu-B6FB8jnSp-xdnx6_2n0AfpmY7PnFH-2OqBb1pgz47Cl1bPl-23V2XOW7kn5sQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 89,98,108,136,154,155  of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-2653626484266847508?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/2653626484266847508/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=2653626484266847508' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2653626484266847508'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2653626484266847508'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/novartis-ags-application-opposition-by_9971.html' title='Novartis AG’s Application/ Opposition by Cipla Ltd (No 1602/MAS/1998)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5339171717274371011</id><published>2008-11-17T07:59:00.000-08:00</published><updated>2008-11-17T09:23:09.507-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>National Institute of Virology’s Application/ Opposition by Vandana S Bhide [No 187163 (581/BOM/1999)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/581-bom-99+National+viriology+vandhana.pdf?gda=WkAEM1wAAADfRe7hc4_l5Qxcp09gGRdPsjtNI81KzBLbO_Wj5jEiqtFQWie12lHcuOpakR9BFUge_Bw8dRiq7DNYfsBT1g2tP_w3H6_5m21F0xBw_TvR0f1ab5qObNWgAVSUTtz98C0&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here &lt;/a&gt;for the decision. For more details see page 153 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5339171717274371011?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5339171717274371011/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5339171717274371011' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5339171717274371011'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5339171717274371011'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/national-institute-of-virologys.html' title='National Institute of Virology’s Application/ Opposition by Vandana S Bhide [No 187163 (581/BOM/1999)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5465439181350595460</id><published>2008-11-17T07:57:00.000-08:00</published><updated>2008-11-17T09:24:01.365-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Natco’s Application for Compulsory Licence IN/PCT/2002/00785/DEL (Patent No 209251)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/in+pct+2002+00785+del.pdf?gda=m3PGjksAAADfRe7hc4_l5Qxcp09gGRdPuakrSuwRrWwx_QzKYB7DGAHzylu31ne3msl8zVf7tsxH8nvkyKFIDVqHuN9MDDw5BkXa90K8pT5MNmkW1w_4BQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here &lt;/a&gt;for the decision. For more details see page 155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5465439181350595460?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5465439181350595460/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5465439181350595460' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5465439181350595460'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5465439181350595460'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/natcos-application-for-compulsory.html' title='Natco’s Application for Compulsory Licence IN/PCT/2002/00785/DEL (Patent No 209251)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-3433191107117010195</id><published>2008-11-17T07:56:00.000-08:00</published><updated>2008-11-17T09:25:04.154-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Marico Industries Ltd’s Application/ Opposition by Hindustan Lever Ltd [No 187164 (782/BOM/1999)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/782-mum-1999.pdf?gda=QvEcwEIAAADfRe7hc4_l5Qxcp09gGRdPu1zW5UP5NexhosOBxGRABFOot7myeh_mfhzNV4vpl0lV4u3aa4iAIyYQIqbG9naPgh6o8ccLBvP6Chud5KMzIQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 116 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-3433191107117010195?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/3433191107117010195/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=3433191107117010195' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3433191107117010195'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3433191107117010195'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/marico-industries-ltds-application.html' title='Marico Industries Ltd’s Application/ Opposition by Hindustan Lever Ltd [No 187164 (782/BOM/1999)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1076078660363770135</id><published>2008-11-17T07:55:00.000-08:00</published><updated>2008-11-17T09:25:56.034-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Malavika Vinodkumar and Krishnamachari Ramu’s Application/ Opposition by Hindustan Lever Ltd 198399 (931/CHE/2003)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/931-che-2003+-+malavika+HLL+postgrant.pdf?gda=FJesh1sAAADfRe7hc4_l5Qxcp09gGRdPSRTdjY6M4fkrCzAE7kFXelbUTVTxDgVGXHsC6XENsrpQmiy3sWjwcN7_LLD02_f-3JljLKpAI9KJiIO4Iq9-IgZF2vdCvKU-TDZpFtcP-AU&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 135 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1076078660363770135?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1076078660363770135/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1076078660363770135' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1076078660363770135'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1076078660363770135'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/malavika-vinodkumar-and-krishnamachari.html' title='Malavika Vinodkumar and Krishnamachari Ramu’s Application/ Opposition by Hindustan Lever Ltd 198399 (931/CHE/2003)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-6150625707022552465</id><published>2008-11-17T07:53:00.000-08:00</published><updated>2008-11-17T09:26:46.329-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Beyond opposition'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 9'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Mahesh Gupta’s Application/ Opposition by Eureka Forbes Ltd (No 1887/DEL/2005)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1887del2005-review.pdf?gda=cUecTEgAAADfRe7hc4_l5Qxcp09gGRdPrml2F0eYwcdyFzCkOHlvSYDqzN0GCNN8QFqIuDe2-2CmwwmmjY8lLEkm5GsdcWpfGjVgdwNi-BwrUzBGT2hOzg&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-6150625707022552465?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/6150625707022552465/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=6150625707022552465' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6150625707022552465'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6150625707022552465'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/mahesh-guptas-application-opposition-by.html' title='Mahesh Gupta’s Application/ Opposition by Eureka Forbes Ltd (No 1887/DEL/2005)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1194567063006791040</id><published>2008-11-17T07:52:00.000-08:00</published><updated>2008-11-17T09:27:30.192-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Magotteaux International’s Application/ Opposition by AIA Engineering Ltd [No 197257 (2769/DEL/1997)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/2769+del+97.pdf?gda=Zwpd3kEAAADfRe7hc4_l5Qxcp09gGRdPwp0R6696R2uRkSe13VCkbAqOIIVxNDHxkgafbhA1bW9TCT_pCLcFTwcI3Sro5jAzlXFeCn-cdYleF-vtiGpWAA&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 154 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1194567063006791040?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1194567063006791040/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1194567063006791040' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1194567063006791040'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1194567063006791040'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/magotteaux-internationals-application.html' title='Magotteaux International’s Application/ Opposition by AIA Engineering Ltd [No 197257 (2769/DEL/1997)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1358897484757548861</id><published>2008-11-17T07:50:00.000-08:00</published><updated>2008-11-17T09:28:28.571-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Intel Corporation’s Application (No 558/DELNP/2005)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/558-delnp-2005.pdf?gda=T9L5CEQAAADfRe7hc4_l5Qxcp09gGRdPhE7BKToxP57pnE0iqBKIRErluGZDwwDAVfd2uq2mpORV6u9SiETdg0Q2ffAyHU-dzc4BZkLnSFWX59nr5BxGqA&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 94 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1358897484757548861?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1358897484757548861/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1358897484757548861' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1358897484757548861'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1358897484757548861'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/intel-corporations-application-no.html' title='Intel Corporation’s Application (No 558/DELNP/2005)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-9185480122142091871</id><published>2008-11-17T07:49:00.000-08:00</published><updated>2008-11-17T09:49:40.629-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Indian Council of Medical Research’s Application (No 244/Del/1999)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/244-del-1999.pdf?gda=TlRRREIAAADfRe7hc4_l5Qxcp09gGRdPnJbkUgagPfFD01CxHLBOcjzZ1TyhjUDTSqsW0RyQC99V4u3aa4iAIyYQIqbG9naPgh6o8ccLBvP6Chud5KMzIQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 118 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-9185480122142091871?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/9185480122142091871/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=9185480122142091871' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/9185480122142091871'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/9185480122142091871'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/indian-council-of-medical-researchs.html' title='Indian Council of Medical Research’s Application (No 244/Del/1999)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-2547558112580165673</id><published>2008-11-17T07:47:00.000-08:00</published><updated>2008-11-17T09:50:27.407-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Honda’s Application/ Opposition by Kinetic Motor Co Ltd (No 948/DEL/1993)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/948-del-93.pdf?gda=yAM3v0AAAADfRe7hc4_l5Qxcp09gGRdPYxUN-AhhCcjK-pb8FmSvS-VGWvICWYQFxxebEGgcykZtxVPdW1gYotyj7-X7wDON&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 108 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-2547558112580165673?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/2547558112580165673/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=2547558112580165673' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2547558112580165673'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2547558112580165673'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hondas-application-opposition-by.html' title='Honda’s Application/ Opposition by Kinetic Motor Co Ltd (No 948/DEL/1993)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-4555783675058745791</id><published>2008-11-17T07:46:00.000-08:00</published><updated>2008-11-17T21:35:10.129-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by Whirlpool of India Ltd [No 192702 (749/BOM/1998)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/749-mum-1998+HLL+Whirlpool.pdf?gda=2fR0qFAAAADfRe7hc4_l5Qxcp09gGRdP-Xgy6nFFTaT45F2cNwwcCooGsZYJQxcXid7N3xj8BT6g9w0LkY4v1s-8USJ8kPGTbcVT3VtYGKLco-_l-8AzjQ&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see page 154 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-4555783675058745791?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/4555783675058745791/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=4555783675058745791' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4555783675058745791'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4555783675058745791'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application.html' title='Hindustan Lever Ltd’s Application/ Opposition by Whirlpool of India Ltd [No 192702 (749/BOM/1998)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-7605979437340881538</id><published>2008-11-17T07:44:00.000-08:00</published><updated>2008-11-17T21:34:36.099-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 181416(129/BOM/1994)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/129+bom+94+HLL.pdf?gda=Ru_5okQAAADfRe7hc4_l5Qxcp09gGRdPnA8_kpert4Y_hwNBEaF5klAfLZ0gSVXGL4OLUTV7aMdV6u9SiETdg0Q2ffAyHU-dzc4BZkLnSFWX59nr5BxGqA&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 93,107,155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-7605979437340881538?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/7605979437340881538/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=7605979437340881538' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7605979437340881538'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7605979437340881538'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application_17.html' title='Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 181416(129/BOM/1994)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1496907325087395183</id><published>2008-11-17T07:43:00.000-08:00</published><updated>2008-11-17T21:40:41.454-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 6'/><category scheme='http://www.blogger.com/atom/ns#' term='Opposition attraction'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 176112 (303/BOM/1992)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/303-bom-92+HLL+PG.pdf?gda=bNJAgUcAAADfRe7hc4_l5Qxcp09gGRdPYpeQbW2AZ2jCgFhbGflTnFAnVwfGdnvg0T2qzK7G9ldhmrMR3uGvvPr01Poh-10xeV4duv6pDMGhhhZdjQlNAw&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 96,135,152,153 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1496907325087395183?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1496907325087395183/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1496907325087395183' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1496907325087395183'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1496907325087395183'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application_1887.html' title='Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 176112 (303/BOM/1992)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-3242012037230540907</id><published>2008-11-17T07:39:00.000-08:00</published><updated>2008-11-17T21:42:37.691-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 174537 (237/BOM/1992)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/237-bom-92+HLL+PG.pdf?gda=YsAgckcAAADfRe7hc4_l5Qxcp09gGRdPUr7jRzN4us8uJ3DwA8SZ1lbNqJjny9eYPVwbKEGIZghhmrMR3uGvvPr01Poh-10xeV4duv6pDMGhhhZdjQlNAw&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 80,96,135 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-3242012037230540907?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/3242012037230540907/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=3242012037230540907' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3242012037230540907'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/3242012037230540907'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application_2723.html' title='Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 174537 (237/BOM/1992)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-2716914705879144665</id><published>2008-11-17T07:36:00.000-08:00</published><updated>2008-11-18T04:07:27.936-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 173958 (316/BOM/1991)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/316-bom-91+HLL+PG.pdf?gda=ByLMqkcAAADfRe7hc4_l5Qxcp09gGRdPgLIbyV3EsnsZaKmPAQxbSA7ZRw3dK7CoboAvlLEZlethmrMR3uGvvPr01Poh-10xeV4duv6pDMGhhhZdjQlNAw&amp;amp;gsc=g8W5sQsAAACBGznTnvpNVZo15G1LF47N"&gt;here&lt;/a&gt; for the decision. For more details see pages 135,155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-2716914705879144665?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/2716914705879144665/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=2716914705879144665' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2716914705879144665'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2716914705879144665'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application_2395.html' title='Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 173958 (316/BOM/1991)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5001837670331531919</id><published>2008-11-17T07:34:00.000-08:00</published><updated>2008-11-18T04:08:57.847-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 174044 (249/B0M/1991)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/249-bom-91+HLL+PG.pdf?gda=cSLBXkcAAADfRe7hc4_l5Qxcp09gGRdPTkNeDx-8PZLkGwb6SASK5jQT2BO6En3wpNYVy3GXL2dhmrMR3uGvvPr01Poh-10xeV4duv6pDMGhhhZdjQlNAw"&gt;here&lt;/a&gt; for the decision. For more details see pages 93,135 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5001837670331531919?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5001837670331531919/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5001837670331531919' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5001837670331531919'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5001837670331531919'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application_7594.html' title='Hindustan Lever Ltd’s Application/ Opposition by Procter &amp; Gamble Far East Inc [No 174044 (249/B0M/1991)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1307816774553590450</id><published>2008-11-17T07:32:00.000-08:00</published><updated>2008-11-18T04:10:02.739-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by P&amp;G [No 174429 (100/BOM/1992)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/100-bom-92+HLL+PG.pdf?gda=C22KNUcAAADfRe7hc4_l5Qxcp09gGRdP3giSfGK6QVfWtSGIqXb8K0HtPUQKsDjDPmisxGx7Xf5hmrMR3uGvvPr01Poh-10xeV4duv6pDMGhhhZdjQlNAw"&gt;here&lt;/a&gt; for the decision. For more details see pages 135,153 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1307816774553590450?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1307816774553590450/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1307816774553590450' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1307816774553590450'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1307816774553590450'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application_1871.html' title='Hindustan Lever Ltd’s Application/ Opposition by P&amp;G [No 174429 (100/BOM/1992)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-1391849163549862079</id><published>2008-11-17T07:31:00.000-08:00</published><updated>2008-11-18T04:10:53.673-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application/ Opposition by Godrej Soaps Ltd [No 176382 (322/BOM/1992)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/322-bom-92+HLL+v+Godrej.pdf?gda=mkA9NU0AAADfRe7hc4_l5Qxcp09gGRdP-wWC77sQMAXeiMkzySp2AAJq_WXbMr6PvlMLoSWouPJc_ynUrZyaGixYq83GVHSN5Tb_vjspK02CR95VRrtmeQ"&gt;here&lt;/a&gt; for the decision. For more details see page 155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-1391849163549862079?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/1391849163549862079/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=1391849163549862079' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1391849163549862079'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/1391849163549862079'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application_7534.html' title='Hindustan Lever Ltd’s Application/ Opposition by Godrej Soaps Ltd [No 176382 (322/BOM/1992)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5439773335266664691</id><published>2008-11-17T07:29:00.000-08:00</published><updated>2008-11-18T04:12:31.774-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 4'/><category scheme='http://www.blogger.com/atom/ns#' term='Touchstone effect'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hindustan Lever Ltd’s Application (No 63/BOM/1975)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/63-bom-1975.pdf?gda=973UmkEAAADfRe7hc4_l5Qxcp09gGRdP8GF_KCzCdost6AmkPzFOvas-TIkjPFm89--O1xTVGoZTCT_pCLcFTwcI3Sro5jAzlXFeCn-cdYleF-vtiGpWAA"&gt;here&lt;/a&gt; for the decision. For more details see pages 42,93 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5439773335266664691?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5439773335266664691/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5439773335266664691' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5439773335266664691'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5439773335266664691'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hindustan-lever-ltds-application-no.html' title='Hindustan Lever Ltd’s Application (No 63/BOM/1975)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-7677019530712845599</id><published>2008-11-17T07:27:00.000-08:00</published><updated>2008-11-18T04:13:46.713-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Hakim Abdul Hameed’s Application/ Opposition by Raj Mehrotra and Dabur Research Foundation [No 183200 (610/DEL/1995)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/610-del-95+unani.pdf?gda=IIIsoEYAAADfRe7hc4_l5Qxcp09gGRdPx7shCHdP6HBtER5hJ9-6F8ujjFkNLGRIrPH3iP_p5864qzmRyw7pERYbIIbTVVQIE-Ea7GxYMt0t6nY0uV5FIQ"&gt;here&lt;/a&gt; for the decision. For more details see page 116 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-7677019530712845599?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/7677019530712845599/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=7677019530712845599' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7677019530712845599'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7677019530712845599'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/hakim-abdul-hameeds-application.html' title='Hakim Abdul Hameed’s Application/ Opposition by Raj Mehrotra and Dabur Research Foundation [No 183200 (610/DEL/1995)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5476907948528847306</id><published>2008-11-17T07:25:00.000-08:00</published><updated>2008-11-18T04:14:52.588-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Greaves Cotton Co Ltd’s Application/Opposition by Bajaj Auto Ltd [No 176968 (419/BOM/1992)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/419-mum-1992+greaves+cotton+bajaj.pdf?gda=ehkxjlcAAADfRe7hc4_l5Qxcp09gGRdPOlMR9oD8Hay77EPilZ4UMV1wD4QIJfkz0DBP_NGZVXB4F9PQezW7jH4Pc9un3uHcYZqzEd7hr7z69NT6IftdMXleHbr-qQzBoYYWXY0JTQM"&gt;here&lt;/a&gt; for the decision. For more details see page 134 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5476907948528847306?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5476907948528847306/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5476907948528847306' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5476907948528847306'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5476907948528847306'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/greaves-cotton-co-ltds.html' title='Greaves Cotton Co Ltd’s Application/Opposition by Bajaj Auto Ltd [No 176968 (419/BOM/1992)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-6934343766555576719</id><published>2008-11-17T07:22:00.000-08:00</published><updated>2008-11-18T04:17:43.504-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Goodrich Carbohydrates’ Application/ Opposition by Bharat Starch Industries (No 659/DEL/2003)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/659del2003+gluten+from+rice.pdf?gda=3u8ru1EAAADfRe7hc4_l5Qxcp09gGRdPPxe2WUaZRjr0P5bXXauL-pWvauZmKlUK_fd7kDNlG7g0_-7dP8On8QChRvABYUKvUwk_6Qi3BU8HCN0q6OYwM5VxXgp_nHWJXhfr7YhqVgA"&gt;here&lt;/a&gt; for the decision. For more details see pages 114,154 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-6934343766555576719?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/6934343766555576719/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=6934343766555576719' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6934343766555576719'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6934343766555576719'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/goodrich-carbohydrates-application.html' title='Goodrich Carbohydrates’ Application/ Opposition by Bharat Starch Industries (No 659/DEL/2003)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-4520636537356142350</id><published>2008-11-17T07:17:00.000-08:00</published><updated>2008-11-18T04:25:41.132-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>F Hoffmann-La Roche Ltd’s Application/ Opposition by Ranbaxy Laboratories Ltd (190/MAS/1998)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/190-mas-98+roche+ranbaxy.pdf?gda=fhE4ZU4AAADfRe7hc4_l5Qxcp09gGRdPMEU81rdIF9Q_-0yr0mRm-Gf-xsEizbzhdeSfM9VUrzkKZMzPCjY7a6fwg2r26udR47Cl1bPl-23V2XOW7kn5sQ"&gt;here&lt;/a&gt; for the decision. For more details see pages 85,86,108,136,155 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-4520636537356142350?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/4520636537356142350/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=4520636537356142350' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4520636537356142350'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4520636537356142350'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/f-hoffmann-la-roche-ltds-application.html' title='F Hoffmann-La Roche Ltd’s Application/ Opposition by Ranbaxy Laboratories Ltd (190/MAS/1998)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-6194916619484380881</id><published>2008-11-17T04:22:00.000-08:00</published><updated>2008-11-18T04:26:56.097-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Enkay (India) Rubber Co Ltd’s Application/ Opposition by Paradise Rubber Industries [No 193340 (1343/DEL/1999)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1343+del+99+193340+costs+on+opponent.pdf?gda=vk63wloAAADfRe7hc4_l5Qxcp09gGRdPmJ8G0DGc30RkqQ7NfFMarZ60CvTscyO1ZLae8NbjfaHoiV7PmSQSHIPIa7cawxdNBj3EwSMQr4yK2U4cnLrwnP3t1oNBp6n3SjsA6lIodbQ&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see page  117 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-6194916619484380881?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/6194916619484380881/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=6194916619484380881' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6194916619484380881'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6194916619484380881'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/enkay-india-rubber-co-ltds-application.html' title='Enkay (India) Rubber Co Ltd’s Application/ Opposition by Paradise Rubber Industries [No 193340 (1343/DEL/1999)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-4502732294092043744</id><published>2008-11-17T04:20:00.000-08:00</published><updated>2008-11-18T04:28:11.276-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 4'/><category scheme='http://www.blogger.com/atom/ns#' term='Touchstone effect'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Enkay (India) Rubber Co Ltd’s Application/ Opposition by Paradise Rubber Industries [No 193339 (1342/DEL/1999)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1342+del+99+193339+costs+on+opponent.pdf?gda=hLXSMFoAAADfRe7hc4_l5Qxcp09gGRdPmJ8G0DGc30RkqQ7NfFMarXCVh9c_7yjhKqvONkPz-FDoiV7PmSQSHIPIa7cawxdNBj3EwSMQr4yK2U4cnLrwnP3t1oNBp6n3SjsA6lIodbQ&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see pages 117,151 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-4502732294092043744?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/4502732294092043744/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=4502732294092043744' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4502732294092043744'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4502732294092043744'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/enkay-india-rubber-co-ltds-application_17.html' title='Enkay (India) Rubber Co Ltd’s Application/ Opposition by Paradise Rubber Industries [No 193339 (1342/DEL/1999)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-613945900464460206</id><published>2008-11-17T04:18:00.000-08:00</published><updated>2008-11-18T04:30:08.898-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Eli Lilly’s Application/ Opposition by Ranbaxy (85/DEL/1995)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/85del95+eli+lilly+ranbaxy.pdf?gda=PWu8408AAADfRe7hc4_l5Qxcp09gGRdP4xXauLL8OuPoZP55IpNjblG8mUw9u9jLAtvcm7rW1xhYvWdDJMkC_jM8SJAm6XW2nHMhSp_qzSgvndaTPyHVdA&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see pages 117,136,154 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-613945900464460206?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/613945900464460206/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=613945900464460206' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/613945900464460206'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/613945900464460206'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/eli-lillys-application-opposition-by.html' title='Eli Lilly’s Application/ Opposition by Ranbaxy (85/DEL/1995)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5357683458165445406</id><published>2008-11-17T04:16:00.000-08:00</published><updated>2008-11-18T10:08:53.213-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 4'/><category scheme='http://www.blogger.com/atom/ns#' term='Touchstone effect'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Eli Lilly’s Application/Opposition by Ajanta Pharma Ltd (No 85/DEL/1995)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/85del95-+eli+lilly+ajanta.pdf?gda=lgUv5U8AAADfRe7hc4_l5Qxcp09gGRdP4xXauLL8OuPoZP55IpNjbvKCo2BzLHCEq3qdioYnzn7-XhhAEFhVSoupBI2NG5sUnHMhSp_qzSgvndaTPyHVdA&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see pages 45,76,86,95,112, 113,115,117 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5357683458165445406?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5357683458165445406/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5357683458165445406' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5357683458165445406'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5357683458165445406'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/eli-lillys-applicationopposition-by.html' title='Eli Lilly’s Application/Opposition by Ajanta Pharma Ltd (No 85/DEL/1995)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-8453733196035467772</id><published>2008-11-17T04:14:00.000-08:00</published><updated>2008-11-18T04:34:31.453-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>EBZ Online Pvt Ltd’s Application (No 994/MUM/2003)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/994-mum-2003-ezl+online.pdf?gda=zsWqNU0AAADfRe7hc4_l5Qxcp09gGRdPM-Fq8Dd0Xan8xqfmeYvt4T_us8aPuxMbITBejiAn03fDIjTMJr83hIpSf2ZNVetT5Tb_vjspK02CR95VRrtmeQ&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see page 94 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-8453733196035467772?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/8453733196035467772/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=8453733196035467772' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8453733196035467772'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8453733196035467772'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/ebz-online-pvt-ltds-application-no.html' title='EBZ Online Pvt Ltd’s Application (No 994/MUM/2003)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5269917814824867737</id><published>2008-11-17T04:11:00.000-08:00</published><updated>2008-11-18T04:35:39.537-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Crompton Greaves Ltd’s Application/ Opposition by Bharat Heavy Electrical Ltd [No 184657 (221/BOM/1996)]</title><content type='html'>Click&lt;a href="http://pharmapatent.googlegroups.com/web/221-bom-96+crompton+greaves+BHEL.pdf?gda=8dP9jVYAAADfRe7hc4_l5Qxcp09gGRdP7_jYWDcz5bpQ3M9Trfgl8PT2UY5x-gZrssCXutW9oRrgF0WaMfhwCeHIC5ERx_wIuKs5kcsO6REWGyCG01VUCBPhGuxsWDLdLep2NLleRSE&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt; here&lt;/a&gt; for the decision. For more details see pages 107,108,117 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5269917814824867737?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5269917814824867737/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5269917814824867737' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5269917814824867737'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5269917814824867737'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/crompton-greaves-ltds-application.html' title='Crompton Greaves Ltd’s Application/ Opposition by Bharat Heavy Electrical Ltd [No 184657 (221/BOM/1996)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-8991086677032461302</id><published>2008-11-17T04:09:00.000-08:00</published><updated>2008-11-18T04:36:19.318-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Chandrakant Damodardas Gandhi’s Application/ ITC Ltd [No 181397 (291/BOM/1994)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/291-bom-94+chandrakant+ITC.pdf?gda=jghoL1AAAADfRe7hc4_l5Qxcp09gGRdPAO-LQ0ep9gXjLOc5LBfnofWAArA8uJjLEEiWCqvZokDM5D0moZpLpfeKx5VGiVbBbcVT3VtYGKLco-_l-8AzjQ&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see page 114 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-8991086677032461302?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/8991086677032461302/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=8991086677032461302' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8991086677032461302'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8991086677032461302'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/chandrakant-damodardas-gandhis.html' title='Chandrakant Damodardas Gandhi’s Application/ ITC Ltd [No 181397 (291/BOM/1994)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-964732937445489988</id><published>2008-11-17T04:07:00.001-08:00</published><updated>2008-11-18T04:38:16.235-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Boehringer Ingelheim’s Application/ Opposition by Cipla Ltd (No 2632/DELNP/2005)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/2632+delnp+2005.pdf?gda=zeBqDUUAAADfRe7hc4_l5Qxcp09gGRdP0AZ0TuynWZNCizxn7Xy57DHbEZoca7gPtvzIx9DTQiUcn8WIbWh5zqeDKtDBmq67Gu1iLHeqhw4ZZRj3RjJ_-A&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see pages 76,91,92,106 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-964732937445489988?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/964732937445489988/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=964732937445489988' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/964732937445489988'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/964732937445489988'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/6-boehringer-ingelheims-application.html' title='Boehringer Ingelheim’s Application/ Opposition by Cipla Ltd (No 2632/DELNP/2005)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-4520412625755516823</id><published>2008-11-17T03:58:00.000-08:00</published><updated>2008-11-18T04:38:52.839-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Beckton, Dickinson and Co’s Application (No 1200/CHENP/2005)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1200-chenp-05.pdf?gda=oYmXCkMAAADfRe7hc4_l5Qxcp09gGRdPrPF0qX4hgSjEigeWFyXTXVAGPF9HsET3J5dS0MPdlRIytiJ-HdGYYcPi_09pl8N7FWLveOaWjzbYnpnkpmxcWg&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see page 94 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-4520412625755516823?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/4520412625755516823/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=4520412625755516823' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4520412625755516823'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/4520412625755516823'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/beckton-dickinson-and-cos-application.html' title='Beckton, Dickinson and Co’s Application (No 1200/CHENP/2005)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-5960673300736436871</id><published>2008-11-17T03:30:00.000-08:00</published><updated>2008-11-18T04:40:29.136-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 3'/><category scheme='http://www.blogger.com/atom/ns#' term='Re-inventing inventions'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>AstraZeneca’s Application/ Opposition by Torrent Pharmaceuticals Ltd (No 1120/DEL/1995)</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/1120-del-95.pdf?gda=uyoyFUEAAADfRe7hc4_l5Qxcp09gGRdPhLz5ZSapk4Lwwt8fVbhttfh46yUGlYxa5Zvsb_9SjaBTCT_pCLcFTwcI3Sro5jAzlXFeCn-cdYleF-vtiGpWAA&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see pages 150,153 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-5960673300736436871?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/5960673300736436871/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=5960673300736436871' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5960673300736436871'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/5960673300736436871'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/astrazenecas-application-opposition-by.html' title='AstraZeneca’s Application/ Opposition by Torrent Pharmaceuticals Ltd (No 1120/DEL/1995)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-8203879199838332420</id><published>2008-11-17T03:27:00.001-08:00</published><updated>2008-11-18T04:41:49.547-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Automotive Research Association of India’s Application/Opposition by Bajaj Auto Ltd [No 176906 (223/BOM/1993)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/223-bom-93+Asso+Bajaj.pdf?gda=nrVs6EsAAADfRe7hc4_l5Qxcp09gGRdP7_jYWDcz5bpQ3M9Trfgl8FPrnEKImrkeeg1DVKslD-fwrDEQF36u_O0XeT4dqaKmBkXa90K8pT5MNmkW1w_4BQ&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see pages 117,134 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-8203879199838332420?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/8203879199838332420/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=8203879199838332420' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8203879199838332420'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/8203879199838332420'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/automotive-research-association-of.html' title='Automotive Research Association of India’s Application/Opposition by Bajaj Auto Ltd [No 176906 (223/BOM/1993)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-6167367578291597708</id><published>2008-11-17T03:23:00.000-08:00</published><updated>2008-11-18T04:42:45.276-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 7'/><category scheme='http://www.blogger.com/atom/ns#' term='Grounds'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>AstraZeneca UK Ltd’s Application/ Opposition by GM Pharma Ltd (No 841/DEL/1996)</title><content type='html'>Click&lt;a href="http://pharmapatent.googlegroups.com/web/841-del-1996%281%29.pdf?gda=22482EkAAADfRe7hc4_l5Qxcp09gGRdP0m8jkwqxMzFIHR9yYGNU9SB8fSC1WwC-s23ssxtz6EAkdgrQlFFtUle5NQqZ_qmzhAioEG5q2hncZWbpWmJ7IQ&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt; here&lt;/a&gt; for the decision. For more details see pages 91,118 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-6167367578291597708?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/6167367578291597708/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=6167367578291597708' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6167367578291597708'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/6167367578291597708'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/astrazeneca-uk-ltds-application.html' title='AstraZeneca UK Ltd’s Application/ Opposition by GM Pharma Ltd (No 841/DEL/1996)'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-216971287770325479</id><published>2008-11-17T03:16:00.000-08:00</published><updated>2008-11-18T04:48:44.515-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 10'/><category scheme='http://www.blogger.com/atom/ns#' term='Strategy'/><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Alphacon Containers Pvt Ltd’s Application/ Opposition by Hindustan Lever Ltd [No 190644 (102/BOM/1998)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/102-bom-98+alhpacon+HLL.pdf?gda=gqUDHk0AAADfRe7hc4_l5Qxcp09gGRdPU3iF_CLqvtWOmgcR9qYpEB_oY7qcmnK1EYLHJ3ct7vUuVRqQOcUgnCP03Tzop6Vw5Tb_vjspK02CR95VRrtmeQ&amp;amp;gsc=eBZdAwsAAAD3mXcMCKdaD-fFD0351zFq"&gt;here&lt;/a&gt; for the decision. For more details see pages 107,110,135 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-216971287770325479?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/216971287770325479/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=216971287770325479' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/216971287770325479'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/216971287770325479'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/alphacon-containers-pvt-ltds.html' title='Alphacon Containers Pvt Ltd’s Application/ Opposition by Hindustan Lever Ltd [No 190644 (102/BOM/1998)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-7213840955784918807</id><published>2008-11-09T05:04:00.000-08:00</published><updated>2008-11-09T22:35:06.171-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Practice'/><category scheme='http://www.blogger.com/atom/ns#' term='Chapter 8'/><category scheme='http://www.blogger.com/atom/ns#' term='Controller&apos;s Decision'/><title type='text'>Vinay Kumar Shridhar’s Application/ Opposition by Pavuluri Rama Lakshmana Rao [No 177423 (62/BOM/1993)]</title><content type='html'>Click &lt;a href="http://pharmapatent.googlegroups.com/web/62-bom-93%20vinay%20kumar%20pavulari.pdf?gsc=FsTupwsAAADLFHM_LYrH1afs6q86Ugyt"&gt;here&lt;/a&gt; for the decision. For more details see page 115 of the Book.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-7213840955784918807?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/7213840955784918807/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=7213840955784918807' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7213840955784918807'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/7213840955784918807'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/11/vinay-kumar-shridhars-application.html' title='Vinay Kumar Shridhar’s Application/ Opposition by Pavuluri Rama Lakshmana Rao [No 177423 (62/BOM/1993)]'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4943785529918190981.post-2787421812572032736</id><published>2008-07-09T21:43:00.001-07:00</published><updated>2008-11-23T19:51:20.510-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='introduction'/><category scheme='http://www.blogger.com/atom/ns#' term='black swan'/><category scheme='http://www.blogger.com/atom/ns#' term='book'/><title type='text'>About the Book</title><content type='html'>&lt;span style="font-size:100%;"&gt;&lt;span style="font-family:georgia;"&gt;What is a Black Swan?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-family:georgia;"&gt;In the field of innovation, a Black Swan popularly refers to a rare, high impact and unpredictable innovation that can bring unprecedented success to any business. Most of the path-breaking, radical technologies that we see around us are Black Swan innovations. And every technology company is looking out for Black Swans and means of protecting them. The law of patents offers the most-comprehensive means of protecting the Black Swan. While it is one thing to offer patent protection for the genuine Black Swans – the real, radical innovations that are novel and non-obvious, it is entirely another thing when old and obvious innovations are patented as new – an ordinary swan painted black! ‘Painting the swan black’ metaphorically refers to passing of a white swan as black (patenting inventions that are obvious) or doing a paint job to refurbish an old black swan to look new (making superficial changes to an earlier invention to qualify for a fresh grant). Both can have adverse affect on business and the development of technology.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;em style="font-family: georgia;"&gt;"The Touchstone Effect: The Impact of Pre-grant Opposition on Patents"&lt;/em&gt;&lt;span style="font-family:georgia;"&gt; explores the strategic use of pre-grant opposition as a touchstone to test the genuineness of an invention. In a comprehensible do-it-yourself fashion, it guides you to develop an in-house, efficient and cost-effective strategy for challenging patents before their grant. It also gets to the other side to tell you what you should do if your patent application is opposed – that is, if you really have a Black Swan to protect.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;About the Author&lt;br /&gt;&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;o:smarttagtype style="font-family: georgia;" namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="PlaceType"&gt;&lt;/o:smarttagtype&gt;&lt;/span&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;  &lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if !mso]&gt;&lt;object classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id="ieooui"&gt;&lt;/object&gt; &lt;style&gt; st1\:*{behavior:url(#ieooui) } &lt;/style&gt; &lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal  {mso-style-parent:"";  margin:0in;  margin-bottom:.0001pt;  mso-pagination:widow-orphan;  font-size:12.0pt;  font-family:"Times New Roman";  mso-fareast-font-family:"Times New Roman";  mso-ansi-language:EN-GB;} @page Section1  {size:8.5in 11.0in;  margin:1.0in 1.25in 1.0in 1.25in;  mso-header-margin:.5in;  mso-footer-margin:.5in;  mso-paper-source:0;} div.Section1  {page:Section1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Table Normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-parent:"";  mso-padding-alt:0in 5.4pt 0in 5.4pt;  mso-para-margin:0in;  mso-para-margin-bottom:.0001pt;  mso-pagination:widow-orphan;  font-size:10.0pt;  font-family:"Times New Roman";} &lt;/style&gt; &lt;![endif]--&gt;    &lt;p class="MsoNormal"  style="text-align: justify;font-family:georgia;"&gt;&lt;span  lang="EN-GB" style="font-size:100%;"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;span style=";font-family:georgia;font-size:100%;"   lang="EN-GB"&gt;Feroz Ali Khader is the best-selling author of &lt;i style=""&gt;The Law of Patents – With a Special Focus on Pharmaceuticals in India&lt;/i&gt;, a unique legal work which offers free online updates innovatively through a blog (&lt;u&gt;&lt;/u&gt;&lt;/span&gt;&lt;a href="http://www.thelawofpatents.blogspot.com"&gt;www.thelawofpatents.blogspot.com&lt;/a&gt;)&lt;span style=";font-family:georgia;font-size:100%;"   lang="EN-GB"&gt;. Since his last academic outing at &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;st1:place  style="font-family:georgia;"&gt;&lt;st1:placename&gt;&lt;span lang="EN-GB"&gt;Trinity&lt;/span&gt;&lt;/st1:placename&gt;&lt;span lang="EN-GB"&gt; &lt;/span&gt;&lt;st1:placetype&gt;&lt;span lang="EN-GB"&gt;College&lt;/span&gt;&lt;/st1:placetype&gt;&lt;/st1:place&gt;&lt;/span&gt;&lt;span style=";font-family:georgia;font-size:100%;"   lang="EN-GB"&gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;st1:place  style="font-family:georgia;"&gt;&lt;st1:placetype&gt;&lt;span lang="EN-GB"&gt;University&lt;/span&gt;&lt;/st1:placetype&gt;&lt;span lang="EN-GB"&gt; of &lt;/span&gt;&lt;st1:placename&gt;&lt;span lang="EN-GB"&gt;Cambridge&lt;/span&gt;&lt;/st1:placename&gt;&lt;/st1:place&gt;&lt;/span&gt;&lt;span style=";font-family:georgia;font-size:100%;"   lang="EN-GB"&gt;, he has settled down in Chennai and practices in the Madras High Court. When he is not involved as an advocate in contentious proceedings, he is engaged in lecturing, teaching and conducting workshops on patent law and practice.&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4943785529918190981-2787421812572032736?l=thetouchstoneeffect.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://thetouchstoneeffect.blogspot.com/feeds/2787421812572032736/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4943785529918190981&amp;postID=2787421812572032736' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2787421812572032736'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4943785529918190981/posts/default/2787421812572032736'/><link rel='alternate' type='text/html' href='http://thetouchstoneeffect.blogspot.com/2008/07/what-is-black-swan_09.html' title='About the Book'/><author><name>Feroz Ali</name><uri>http://www.blogger.com/profile/13043465598639194820</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>
